Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Accolade, Inc. - common stock
(NQ:
ACCD
)
7.020
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Accolade, Inc. - common stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
↗
March 01, 2025
Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS.
Via
Benzinga
Topics
Artificial Intelligence
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
February 25, 2025
From
Halper Sadeh LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, FNA, LGTY, ACCD on Behalf of Shareholders
February 19, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)
February 19, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
↗
February 08, 2025
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.
Via
Benzinga
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
↗
January 31, 2025
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.
Via
Benzinga
Cathie Wood's Wednesday Moves: Ark Invest Dumps Robinhood Stock
↗
January 22, 2025
On Wednesday January 22, 2025, Cathie Wood-led Ark Invest sold $927,107 worth of Robinhood shares.
Via
Benzinga
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
↗
January 22, 2025
Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.
Via
Benzinga
Topics
Government
Accolade Q3 Earnings Assessment
↗
January 10, 2025
Via
Benzinga
Earnings Scheduled For January 9, 2025
↗
January 09, 2025
Via
Benzinga
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia
↗
January 18, 2025
Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.
Via
Benzinga
Topics
Artificial Intelligence
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)
January 13, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
January 11, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
What's Going On With Accolade Stock Wednesday?
↗
January 08, 2025
Accolade shares are trading higher on Wednesday after it announced that Transcarent will acquire the company.
Via
Benzinga
Breaking Down Accolade: 8 Analysts Share Their Views
↗
December 17, 2024
Via
Benzinga
ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD
January 08, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 08, 2025
Via
Benzinga
Why Is Accolade Stock Trading Over 100% On Tuesday?
↗
January 08, 2025
Transcarent to acquire Accolade Inc. for $7.03 per share, combining AI-driven care solutions with personalized healthcare expertise. Deal closes Q2 2025.
Via
Benzinga
Shareholder Alert: Ademi LLP Investigates Whether Accolade, Inc. Is Obtaining a Fair Price for Its Public Shareholders
January 08, 2025
From
Ademi LLP
Via
Business Wire
Forecasting The Future: 6 Analyst Projections For Accolade
↗
October 09, 2024
Via
Benzinga
Uncovering Potential: Accolade's Earnings Preview
↗
October 07, 2024
Via
Benzinga
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings
↗
October 04, 2024
Via
Benzinga
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
January 08, 2025
From
Halper Sadeh LLC
Via
Business Wire
Transcarent To Acquire Accolade
January 08, 2025
From
Transcarent
Via
Business Wire
Transcarent To Acquire Accolade
January 08, 2025
From
Accolade, Inc.
Via
GlobeNewswire
Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms
↗
October 08, 2024
Accolade stock up after beating Q2 2025 revenue and EPS estimates, expecting full year Adjusted EBITDA profitability and positive cash flow.
Via
Benzinga
Accolade Announces Results for Fiscal Second Quarter 2025
October 08, 2024
From
Accolade, Inc.
Via
GlobeNewswire
Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone
↗
October 08, 2024
Via
Benzinga
Topics
Stocks
PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday
↗
October 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 04, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
